Goldman Sachs’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.81M | Buy |
|
|||||
|
2025
Q2 | $2.19M | Sell |
|
|||||
|
2025
Q1 | $3.18M | Sell |
|
|||||
|
2024
Q4 | $2.92M | Sell |
|
|||||
|
2024
Q3 | $4.79M | Buy |
|
|||||
|
2024
Q2 | $6.48M | Sell |
|
|||||
|
2024
Q1 | $6.53M | Sell |
|
|||||
|
2023
Q4 | $6.42M | Buy |
|
|||||
|
2023
Q3 | $723K | Buy |
|
|||||
|
2023
Q2 | $759K | Sell |
|
|||||
|
2023
Q1 | $643K | Sell |
|
|||||
|
2022
Q4 | $5.84M | Buy |
|
|||||
|
2022
Q3 | $2.81M | Sell |
|
|||||
|
2022
Q2 | $2.12M | Buy |
|
|||||
|
2022
Q1 | $2.29M | Buy |
|
|||||
|
2021
Q4 | $1.59M | Buy |
|
|||||
|
2021
Q3 | $2.2M | Buy |
|
|||||
|
2021
Q2 | $2.8M | Buy |
|
|||||
|
2021
Q1 | $1.93M | Buy |
|
|||||
|
2020
Q4 | $755K | Sell |
|
|||||
|
2020
Q3 | $400K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $232K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $79K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $92K | Buy |
|
|||||
|
2018
Q3 | $133K | Sell |
|
|||||
|
2018
Q2 | $267K | Buy |
|
|||||
|
2018
Q1 | $233K | Buy |
|
|||||
|
2017
Q4 | $207K | Buy |
|
|||||
|
2017
Q3 | $237K | Sell |
|
|||||
|
2017
Q2 | $396K | Sell |
|
|||||
|
2017
Q1 | $238K | Buy |
|
|||||
|
2016
Q4 | $382K | Buy |
|
|||||
|
2016
Q3 | $241K | Buy |
|
|||||
|
2016
Q2 | $187K | Sell |
|
|||||
|
2016
Q1 | $755K | Sell |
|
|||||
|
2015
Q4 | $3.96M | Buy |
|